News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
220,906 Results
Type
Article (13985)
Company Profile (94)
Press Release (206827)
Section
Business (62857)
Career Advice (387)
Deals (11694)
Drug Delivery (27)
Drug Development (43949)
Employer Resources (21)
FDA (4831)
Job Trends (4797)
News (119264)
Policy (8638)
Tag
Academia (883)
Alliances (18490)
Alzheimer's disease (842)
Antibody-drug conjugate (ADC) (68)
Approvals (4796)
Artificial intelligence (78)
Bankruptcy (69)
Best Places to Work (4381)
Biotechnology (87)
Breast cancer (81)
Cancer (810)
Cardiovascular disease (50)
Career advice (305)
CAR-T (58)
Cell therapy (167)
Clinical research (34498)
Collaboration (239)
Compensation (79)
COVID-19 (936)
C-suite (53)
Cystic fibrosis (57)
Data (796)
Diabetes (76)
Diagnostics (1999)
Earnings (26010)
Events (35818)
Executive appointments (137)
FDA (5100)
Funding (196)
Gene editing (49)
Gene therapy (105)
GLP-1 (287)
Government (1125)
Healthcare (6126)
Infectious disease (982)
Inflammatory bowel disease (87)
Interviews (52)
IPO (6431)
Job creations (651)
Job search strategy (245)
Layoffs (122)
Legal (986)
Lung cancer (140)
Manufacturing (63)
Medical device (2475)
Medtech (2477)
Mergers & acquisitions (5388)
Metabolic disorders (203)
Neuroscience (1016)
NextGen Class of 2024 (1673)
Non-profit (875)
Northern California (865)
Obesity (109)
Opinion (74)
Parkinson's disease (50)
Patents (61)
People (15515)
Phase I (12826)
Phase II (15766)
Phase III (9952)
Pipeline (369)
Postmarket research (653)
Preclinical (5304)
Radiopharmaceuticals (196)
Rare diseases (142)
Real estate (958)
Regulatory (7111)
Research institute (957)
Resumes & cover letters (117)
Southern California (798)
Startups (1452)
United States (6722)
Vaccines (232)
Weight loss (66)
Date
Today (1)
Last 7 days (377)
Last 30 days (2007)
Last 365 days (18933)
2024 (17365)
2023 (20427)
2022 (24745)
2021 (24183)
2020 (20420)
2019 (14512)
2018 (10667)
2017 (11690)
2016 (9938)
2015 (11922)
2014 (7881)
2013 (5999)
2012 (6115)
2011 (6287)
2010 (5499)
Location
Africa (163)
Asia (14714)
Australia (2830)
California (1938)
Canada (604)
China (155)
Colorado (85)
Connecticut (96)
Europe (34163)
Florida (230)
Illinois (104)
Indiana (87)
Japan (51)
Maryland (247)
Massachusetts (1507)
Minnesota (85)
New Jersey (456)
New York (513)
North Carolina (259)
Northern California (865)
Ohio (51)
Pennsylvania (395)
South America (218)
Southern California (798)
Texas (233)
Washington State (238)
220,906 Results for "target pharmasolutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Mikart and Nano PharmaSolutions complete key milestones
Mikart, LLC, a leading contract development and manufacturing organization, is thrilled to announce a significant milestone in its collaboration with Nano PharmaSolutions, Inc..
May 7, 2024
·
2 min read
Approvals
Astellas’ First-in-Class, Claudin-Targeted Therapy Wins FDA Nod for Certain Gastric Cancers
The regulator’s approval on Friday of Vyloy for gastric or gastroesophageal junction cancer makes it the first and only claudin 18.2–targeted therapy approved in the U.S. for these indications, according to Astellas.
October 21, 2024
·
2 min read
·
Tristan Manalac
CRISPR
CRISPR
Ex Vivo
Gene Editing Gets on Target With Caribou’s Hybrid Guides
While
ex vivo
genome editing results in highly effective cell therapies, it can lead to off-target effects. Caribou Biosciences has come up with a novel approach for potentially more precise gene editing compared to all-RNA guides.
October 14, 2024
·
5 min read
·
Greg Slabodkin
Deals
Lilly, Haya Ink Potential $1B Drug Discovery Deal to Target Obesity and Metabolic Conditions
Under a multi-year agreement announced Wednesday, Eli Lilly will leverage Haya Therapeutics’ proprietary RNA-guided genome platform to identify drug targets to address the chronic conditions.
September 4, 2024
·
2 min read
·
Kate Goodwin
Press Releases
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
November 19, 2024
·
8 min read
Series A
Navigator Closes $100M Series A, Targets Autoimmune Market With Potential Best-in-Class Bispecific Antibody
Navigator Medicine is looking to push its lead asset NAV-240 targeting immune-mediated diseases through to clinical studies “in the coming months,” which the startup in-licensed from a South Korean biotech for $20 million upfront.
August 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Cancer Targeted Technology Receives Fast Track $2.4M Grant to Develop an Innovative PSMA-Targeted Small Molecule Drug Conjugate for Prostate Cancer
November 18, 2024
·
2 min read
Press Releases
ElevateBio Announces Advancements of its Proprietary Lipid Nanoparticle (LNP) Delivery Platform with Liver Targeting and De-Targeting Potential
October 16, 2024
·
3 min read
Press Releases
Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
November 13, 2024
·
4 min read
Press Releases
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
November 11, 2024
·
8 min read
1 of 22,091
Next
